Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ripply transcriptional repressor 3 | 0.839 | 0.192 | 8.4E-02 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2011 | 2018 | ||||||||
|
tubulin beta 2B class IIb | 0.610 | 0.385 | 0.99 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2019 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2001 | ||||||||
|
Split-hand/foot malformation with long bone deficiency 1 | 1.000 | 0.038 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2014 | |||||||||
|
ETS2 repressor factor | 0.572 | 0.654 | 0.99 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2019 | ||||||||
|
transcriptional repressor GATA binding 1 | 0.537 | 0.769 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
UV radiation resistance associated | 0.436 | 0.769 | 0.99 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2010 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2009 | ||||||||
|
aristaless related homeobox | 0.516 | 0.654 | 0.91 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2019 | ||||||||
|
Zic family member 2 | 0.556 | 0.769 | 0.97 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2001 | ||||||||
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2019 | ||||||||
|
Rac family small GTPase 1 | 0.429 | 0.962 | 0.76 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
growth hormone 1 | 0.373 | 0.923 | 3.0E-02 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2005 | ||||||||
|
gremlin 1, DAN family BMP antagonist | 0.508 | 0.808 | 0.47 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
GLI family zinc finger 3 | 0.436 | 0.846 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2009 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
ALX homeobox 3 | 0.578 | 0.692 | 1.9E-02 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1980 | 2014 | ||||||||
|
goosecoid homeobox | 0.631 | 0.615 | 1.4E-02 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2017 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | ||||||||
|
solute carrier family 35 member A3 | 0.716 | 0.308 | 2.6E-03 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2017 | ||||||||
|
retinoid isomerohydrolase RPE65 | 0.417 | 0.808 | 6.5E-14 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2010 | ||||||||
|
T-box transcription factor 1 | 0.433 | 0.808 | 0.84 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1996 | 1996 | ||||||||
|
T-box transcription factor 6 | 0.659 | 0.385 | 6.8E-03 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2010 | 2017 | ||||||||
|
ROS proto-oncogene 1, receptor tyrosine kinase | 0.439 | 0.885 | 1.6E-72 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
forkhead box C1 | 0.483 | 0.846 | 0.95 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2007 |